Company intelligence / Profile preview

NextBio

Cupertino, California, United States

Ownership: Private
Employees: ~75
Development stage: Other

Overview

NextBio provided an ontology-based semantic platform enabling life sciences researchers and drug developers to search, integrate, and analyze public and proprietary -omics data. Its technology facilitated hypothesis generation, biomarker discovery, and translational research. Following its acquisition by Illumina in 2013, the platform was rebranded as Correlation Engine and integrated into Illumina's informatics portfolio[1][5].

Industry: Drug Discovery Services

Partnerships

MerckJohnson & Johnson Pharmaceutical R&DCelgeneGenzymeEli Lilly and CompanyRegeneron Pharmaceuticals

Beyond the preview

Go deeper on NextBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NextBio.

Explore the full profile